Journal
CELL
Volume 153, Issue 6, Pages 1327-1339Publisher
CELL PRESS
DOI: 10.1016/j.cell.2013.04.048
Keywords
-
Categories
Funding
- NSF [MCB-0842974, MCB-1243522]
- NIH [RO1CA117907, RO1CA140545]
- Butcher Seed Grant
- Boettcher Foundation's Webb-Waring Biomedical Research program
- DoD Breast Cancer Postdoctoral Fellowship [W81XWH-10-1-0062, 2T15LM009451]
- Div Of Molecular and Cellular Bioscience
- Direct For Biological Sciences [1627615] Funding Source: National Science Foundation
Ask authors/readers for more resources
The transcription factor HIF1A is a key mediator of the cellular response to hypoxia. Despite the importance of HIF1A in homeostasis and various pathologies, little is known about how it regulates RNA polymerase II (RNAPII). We report here that HIF1A employs a specific variant of the Mediator complex to stimulate RNAPII elongation. The Mediator-associated kinase CDK8, but not the paralog CDK19, is required for induction of many HIF1A target genes. HIF1A induces binding of CDK8-Mediator and the super elongation complex (SEC), containing AFF4 and CDK9, to alleviate RNAPII pausing. CDK8 is dispensable for HIF1A chromatin binding and histone acetylation, but it is essential for binding of SEC and RNAPII elongation. Global analysis of active RNAPII reveals that hypoxia-inducible genes are paused and active prior to their induction. Our results provide a mechanistic link between HIF1A and CDK8, two potent oncogenes, in the cellular response to hypoxia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available